Source of an antioxidant
For instance, patients with non-exudative AMD and metabolic risk factors may be ideal candidates, while those with nAMD may require caution and close monitoring if systemic GLP-1RA therapy is initiated for metabolic reasons
Glutathione research, by contrast, focuses primarily on its antioxidant and detoxification properties rather than direct weight loss outcomes
WeGovy (Semaglutide) is a cutting-edge prescription medication approved by the FDA for chronic weight management in adults with obesity, or overweight individuals who have at least one weight-related condition
The medication qualifies for HSA/FSA accounts, and no insurance or membership fee is required
Exendin-4, liraglutide and semaglutide can directly or indirectly stimulate POMC neurons in the ARC, while indirectly inhibiting NPY/AgRP neurons via presynaptic GABAergic neurons [82-84]